Psychopharmacology and Psychiatry Updates

In this episode, we explore relapse prevention strategies for youth with depression and anxiety disorders. Are there effective ways to reduce the risk and prolong the time to relapse? Dr. David Rosenberg discusses the findings of a recent meta-analysis and systematic review on this crucial topic. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 15Relapse Prevention Strategies for Depression and Anxiety in Remitted Youth

In this episode, we navigate the complexities of initiating and optimizing clozapine treatment for patients with treatment-resistant schizophrenia. How do you chart the course for successful clozapine therapy while managing side effects and drug interactions? Join us as Dr. Brian Miller shares his expertise and valuable psychopharmacology pearls. Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CMEs: Clozapine: Management and ChallengesInitiating and Optimizing Clozapine

In this episode, we discuss the prevalence of smoking among people with psychosis, based on recent findings from the PATH study. Dr. Oliver Freudenreich shares insights on how clinicians can prioritize smoking cessation in this population. How can we bridge the health outcome disparities faced by our patients with psychosis? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.75 CMEs: Quick Take Vol. 55Tobacco Use, Nicotine Dependence, and Cessation Among Adults with Psychosis

In this episode, we delve into the use of clozapine for treatment-resistant psychosis and mood disorders. When should clinicians consider clozapine, and what do expert guidelines recommend? Dr. Brian Miller guides us through the evidence and best practices for utilizing this powerful but often underused medication. Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CME: Clozapine: Management and ChallengesUsing Clozapine for Treatment-Resistant Psychosis and Mood Disorders

In this episode, we explore the role of lithium in treating pediatric bipolar disorder and conduct disorder. Is lithium a viable option for managing these complex conditions in children and adolescents, or are other medications more effective? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 14Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood-Related Disorders

In this episode, we explore real-world clinical cases demonstrating how broad-spectrum micronutrients can complement existing interventions for ADHD, emotional dysregulation, and mood instability. Can close monitoring and expert guidance optimize the integration of nutritional supplementation with pharmacologic treatments to create a harmonious, personalized approach? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.75 CMEs: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical UseClinical Cases

In this episode, we discuss the groundbreaking FDA approval of zuranolone, the first oral medication specifically targeting postpartum depression. Could zuranolone's novel mechanism of action as an allopregnanolone agonist herald a new era of rapid-onset, targeted treatments for this debilitating condition affecting 1 in 8 new mothers? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.75 CMEs: Quick Take Vol. 54Zuranolone for the Treatment of Postpartum Depression

In this episode, we explore practical clinical tips for using broad-spectrum micronutrient supplements to treat mental health conditions. Can an individual's nutritional needs surpass population standards? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical UsePractical Tips for Using BSMs in the Clinical Practice

In this episode, we examine whether first-trimester exposure to the antipsychotic olanzapine increases the risk of major fetal malformations. Does stopping medication abruptly also carry risks? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 14Risk of Major Malformations Following First-Trimester Exposure to Olanzapine

In this episode, we delve into the safety considerations of using broad-spectrum micronutrient formulas in mental disorder treatment, mainly how these supplements can interact with other medications. Is it safe to use these formulas alongside anesthesia during surgery? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical UseBSMs and Drug Interactions

In this episode, we explore the potential of NSAIDs in delirium prevention. However, NSAIDs come with risks, such as GI bleeding or kidney injury. Can NSAIDs really help prevent delirium, and if so, how? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.75 CMEs: Quick Take Vol. 54Use of NSAIDs for Delirium Risk Reduction

In this episode, we explore the unconventional yet promising treatment modality of using broad-spectrum micronutrient formulas in mental health care. We discuss the research and clinical trials that have been undertaken to test combinations of vitamins and minerals, focusing on their safety and efficacy. What are the potential side effects of using broad-spectrum micronutrient formulas? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical UseBSMs: Safety and Tolerability

In this episode, we discuss an insightful study by Strawn et al. that utilized a mega-analysis approach, combining data on over 900 MDD patients across lifespan treatment trials to elucidate differences in antidepressant treatment outcomes based on patient age. Does antidepressant efficacy differ across developmental stages—children, adolescents, and adults? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 13Age's Impact on Antidepressant Response

What are some common signs that suggest a cancer patient may be developing delirium? In this episode, we explore the complex issue of delirium in advanced cancer patients. We discuss important considerations regarding medication management, the importance of distinguishing terminal from reversible delirium, and the role of antipsychotics and benzodiazepines in treatment. Faculty: Jaroslava Salman, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CME: Depression, Anxiety, and Delirium in Patients With CancerManagement of Delirium in Patients With Cancer

In this episode, we discuss the treatment of agranulocytosis or neutropenia in patients on clozapine therapy, a rare yet serious scenario that clinicians may encounter. We delve into the possibility of rechallenging clozapine treatment after such an event and explore the use of colony-stimulating factors. What's the likelihood of agranulocytosis while prescribing clozapine long term? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: Quick Take Vol. 53The Impact of Colony-Stimulating Factor on Clozapine Rechallenge Outcomes

In this episode, we delve into the management of anxiety in cancer patients, including the effective psychotherapeutic interventions and pharmacologic options for treating anxiety in this vulnerable group. The episode also touches on the importance of cultural sensitivity and patient education when managing anxiety in cancer patients. Faculty: Jaroslava Salman, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CME: Depression, Anxiety, and Delirium in Patients With CancerTreating Anxiety Disorders in Patients With Cancer

In this podcast episode, Dr. David Rosenberg explores practical strategies to asess and manage common antidepressant side effects in the pediatric population. Get useful takeaways regarding activation, insomnia, withdrawal symptoms, and more. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 13Managing Adverse Effects of Antidepressants in Youth

In this podcast episode, Jaroslava Salman, M.D., discusses the treatment options for depressed patients with cancer. Stay a step ahead in your practice with practical tips on which psychotherapies are helpful, which antidepressants to use and for how long, what to be mindful of, and even insights into prescribing stimulants. Faculty: Jaroslava Salman, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CME: Depression, Anxiety, and Delirium in Patients With CancerTreating Depressive Disorders in Patients With Cancer

In this podcast episode, Dr. Vivien Burt delves into a study on brexanolone for women with postpartum depression, anxiety, and insomnia. Listen in and find out the effect and time frame of brexanolone on these symptoms. Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: Quick Take Vol. 53Effect of Brexanolone on Postpartum Depressive Symptoms, Anxiety, and Insomnia

In this podcast, Dr. David Rosenberg offers practical insights into treatment optimization for youth with tic disorders. Listen in and find out which treatment modality takes precedence, which factors need to be considered, how long to use medication, and more. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.5 CMEs: Tic Disorders in Children and AdolescentsTreatment Optimization for Tic Disorders